Cite
MLA Citation
E Louis et al.. “P631 Long-term safety of vedolizumab versus other biologic agents in ulcerative colitis (UC) and Crohn's Disease (CD): Results from a large multinational prospective observational study.” Journal of Crohn's and colitis, vol. 17, n.d., pp. i762–i763. http://access.bl.uk/ark:/81055/vdc_100179843738.0x000025